China Resources Zizhu Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:China Resources Zizhu Pharmaceutical Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10914
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
China Resources Zizhu Pharmaceutical Co Ltd (Zizhu Pharmaceutical) is a provider of pharmaceutical development, manufacture, and marketing programs. The company offers dietary supplements, women healthcare products, ophthalmology medicines, APIs and intermediates, anesthetic, biological agents and respiratory medicines. Its dietary supplements comprise fresh royal jelly, propolis pellicle, propolis soft capsules, bee pollen soft capsules and royal jelly powder. Zizhu Pharmaceutical’s women healthcare products include contraceptives, medical abortion, hormone replacement theory and endometriosis. The company markets its products through its distributors in China and abroad. Zizhu Pharmaceutical is headquartered in Beijing, China.

China Resources Zizhu Pharmaceutical Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
China Resources Zizhu Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
China Resources Zizhu Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
China Resources Zizhu Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
China Resources Zizhu Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
China Resources Zizhu Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
China Resources Zizhu Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
China Resources Zizhu Pharma Enters into Distribution Agreement with Uni-Bio Science 10
China Resources Zizhu Enters into Agreement with Uni-Bio Science 11
Acquisition 12
Beijing Pharma Rumored To Acquire 42% Stake In Beijing Zizhu Pharma For US$245 Million 12
Beijing Industrial Development And Beijing Zizhu To Sell 24% Stake In China Pharma For US$2 Million 13
China Resources Zizhu Pharmaceutical Co Ltd – Key Competitors 14
China Resources Zizhu Pharmaceutical Co Ltd – Key Employees 15
China Resources Zizhu Pharmaceutical Co Ltd – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
China Resources Zizhu Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
China Resources Zizhu Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
China Resources Zizhu Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
China Resources Zizhu Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
China Resources Zizhu Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
China Resources Zizhu Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
China Resources Zizhu Pharma Enters into Distribution Agreement with Uni-Bio Science 10
China Resources Zizhu Enters into Agreement with Uni-Bio Science 11
Beijing Pharma Rumored To Acquire 42% Stake In Beijing Zizhu Pharma For US$245 Million 12
Beijing Industrial Development And Beijing Zizhu To Sell 24% Stake In China Pharma For US$2 Million 13
China Resources Zizhu Pharmaceutical Co Ltd, Key Competitors 14
China Resources Zizhu Pharmaceutical Co Ltd, Key Employees 15

List of Figures
China Resources Zizhu Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
China Resources Zizhu Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
China Resources Zizhu Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
China Resources Zizhu Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
China Resources Zizhu Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
China Resources Zizhu Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
China Resources Zizhu Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
China Resources Zizhu Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[China Resources Zizhu Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Oi S.A. (OIBR4):企業の財務・戦略的SWOT分析
    Oi S.A. (OIBR4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Banco Bilbao Vizcaya Argentaria, S.A.:企業の戦略・SWOT・財務分析
    SummaryBanco Bilbao Vizcaya Argentaria, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of th …
  • Divergent Energy Services Corp. (DVG):企業の財務及び戦略的SWOT分析
    Summary Divergent Energy Services Corp. (Divergent Energy) formerly Cdn Oilfield Technologies & Solutions Corp. is an energy service provider that offers electric submersible pump (ESP) solutions to oil and gas and mining industry. The company offers third party products and services to both indepen …
  • Reliance Capital Limited:企業の戦略・SWOT・財務分析
    SummaryReliance Capital Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Ke …
  • SECI Energia SpA:企業のM&A・提携動向(エネルギー分野)
    Summary SECI Energia SpA (SECI Energia) is an energy development service provider that specializes in the construction, installation and management of plants. It focuses producing alternative energy through renewable. The company operates in the areas of thermoelectric power, biomass, solar, biogas …
  • Ferrellgas Partners, L.P.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Ferrellgas Partners, L.P. Merge …
  • Cameo Communications, Inc. (6142):企業財務及び戦略的SWOT分析
    Summary Cameo Communications, Inc. (Cameo) is a technology company that offers network equipment manufacturing services. The company manufactures and assembles custom computer network communication equipments and communication products. Its products include layer 2 management ethernet switch, SOHO r …
  • Morphotek Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Morphotek Inc (Morphotek), a subsidiary of Eisai Inc, is a clinical-stage biotechnology company that develops monoclonal antibodies, antibody drug conjugates, and bispecific antibodies to treat cancer, inflammatory and infectious diseases. Its pipeline product portfolio includes farletuzumab …
  • Sah Petroleums Limited (GULFPETRO):企業財務及び戦略的SWOT分析
    Summary Sah Petroleums Limited (Sah Petroleums) is a petroleum products manufacturer that designs, manufactures and markets, industrial and automotive lubricants, process oils, transformer oils, greases and other specialties. The company offers product in the areas of automotive lubricants, industri …
  • Medizone International, Inc. (MZEI):企業の財務及び戦略的SWOT分析
    Summary Medizone International, Inc. (Medizone) is a medical device company that develops disinfectant products used in surgical and other medical treatment facilities. The company product includes AsepticSure hospital sterilization system. Its AsepticSure is an ozone-based technology which is used …
  • Companhia Estadual de Energia Eletrica:企業のM&A・提携動向(発電分野)
    Summary Companhia Estadual de Energia Eletrica (CEEE) is an electric utility that offers generation, transmission, distribution and sale of electricity, and related services. The utility caters to over various municipalities, covering concession area of 73,627 sq. km, which accounts for over 34% of …
  • 2190776 Ontario, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' 2190776 Ontario, Inc. Mergers a …
  • Valtech Cardio Ltd.:企業の製品パイプライン分析2016
    Summary Valtech Cardio Ltd. (Valtech Cardio) is a medical device company that provides percutaneous mitral valve repair technology solutions for replacement and repair of mitral valve. The company offers cardioband system, which is a percutaneous treatment for MR that is based on surgical foundation …
  • Swissmed Centrum Zdrowia SA (SWD):企業のM&A・提携動向(医療分野)
    Summary Swissmed Centrum Zdrowia SA (Swissmed) is a medical organization that constructs and operates health care facilities. The company services include unlimited specialist care, laboratory tests, diagnostic examinations, nursing services and flu vaccination. Swissmed offers laboratory tests for …
  • Royal Dutch Shell plc (RDSA)(エネルギー分野):企業M&A動向
    Summary Royal Dutch Shell plc (Shell) is a leading oil and gas company. It has an integrated operational structure with investments in the oil and gas value chain. Shell classifies its operations into three segments, namely, Upstream, Downstream and Corporate. Its Upstream business explores for, ext …
  • Wipro Ltd:戦略・SWOT・企業財務分析
    Wipro Ltd - Strategy, SWOT and Corporate Finance Report Summary Wipro Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Midatech Pharma Plc (MTPH):企業のM&A・提携動向(医療分野)
    Summary Midatech Pharma Plc (Midatech) is a pharmaceutical company that manufactures and markets oncology and other therapeutic products. The company offers products, which include gelclair, oravig, soltamox, zuplenz, ferralet 90 and aquoral. It provides research and development programs in areas of …
  • Longfor Group Holdings Limited:企業の戦略・SWOT・財務情報
    Longfor Group Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Longfor Group Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Textron, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Textron, Inc. Mergers and Acqui …
  • Hoteli Makarska d.d.:企業の戦略・SWOT・財務分析
    Hoteli Makarska d.d. - Strategy, SWOT and Corporate Finance Report Summary Hoteli Makarska d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆